Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04434365
What this trial is testing

Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

Who this might be right for
Stable Coronary Artery DiseasePercutaneous Coronary Intervention
Peking Union Medical College Hospital 24
Post-approval studies (Phase 4)Looking for participantsNCT04518475
What this trial is testing

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 224
Post-approval studies (Phase 4)Study completedNCT04927949
What this trial is testing

Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not

Who this might be right for
ST-elevation Myocardial Infarction
University Hospital, Caen 128
Post-approval studies (Phase 4)Study completedNCT01848899
What this trial is testing

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Who this might be right for
Coronary Artery Disease
NYU Langone Health 100
Testing effectiveness (Phase 2)UnknownNCT04289207
What this trial is testing

Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Seoul National University Hospital 55
Not applicableStudy completedNCT03199521
What this trial is testing

Assessment of The Effect of Apixaban in AF

Who this might be right for
Atrial FibrillationEmbolism Thrombosis
East and North Hertfordshire NHS Trust 240
Large-scale testing (Phase 3)Active Not RecruitingNCT04861259
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Hoffmann-La Roche 83
Not applicableStudy completedNCT01671007
What this trial is testing

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Who this might be right for
StrokeAtrial Fibrillation
Boehringer Ingelheim 10,471
Post-approval studies (Phase 4)Study completedNCT00171756
What this trial is testing

Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.

Who this might be right for
Hypertension
Novartis 92
Early research (Phase 1)Ended earlyNCT02009761
What this trial is testing

Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Boehringer Ingelheim 6
Not applicableStudy completedNCT03832842
What this trial is testing

Thrombin Generation as a New Test for Anticoagulation Management in Patients With ECMO

Who this might be right for
Implantation of a Veno-arterial or Veno-venous ECMO
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT02073396
What this trial is testing

Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis

Who this might be right for
Atrial FibrillationCoronary Artery Disease
East and North Hertfordshire NHS Trust 140
Testing effectiveness (Phase 2)Study completedNCT03664518
What this trial is testing

To Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

Who this might be right for
Thrombocytopenia PurpuraChronic HBV Infection
Institute of Hematology & Blood Diseases Hospital, China 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07081035
What this trial is testing

Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients

Who this might be right for
Advanced Heart FailureLeft Ventricular Assist DevicesAnticoagulation Treatment+2 more
Asan Medical Center 94
Post-approval studies (Phase 4)Study completedNCT04409834
What this trial is testing

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

Who this might be right for
COVID-19Venous ThromboembolismArterial Thrombosis
The TIMI Study Group 390
Not applicableStudy completedNCT02114307
What this trial is testing

REVITIVE for the Treatment of Patients With Venous Insufficiency

Who this might be right for
Venous InsufficiencyOedemaVaricose Veins
Imperial College London 22
Testing effectiveness (Phase 2)Study completedNCT03384693
What this trial is testing

Defibrotide TMA Prophylaxis Pilot Trial

Who this might be right for
Thrombotic Microangiopathies
University of California, San Francisco 25
Not applicableStudy completedNCT06679699
What this trial is testing

Patient Education Program and Trunk Control Exercises in Post-stroke

Who this might be right for
Strokes Thrombotic
Gulf Medical University 40
Testing effectiveness (Phase 2)UnknownNCT06190145
What this trial is testing

Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 40
Not applicableStudy completedNCT06071520
What this trial is testing

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Who this might be right for
Primary Immune Thrombocytopenia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 50
Next Page